类风湿性关节炎 - 在慢性病中药物剂量
Kinga Maria Tyczyńska1, Hanna Augustyniak-Bartosik2, Jerzy Świerkot1
1Department and Clinic of Rheumatology and Internal Diseases, Wroclaw Medical University, Poland.
Reumatologia
|February 7, 2024
概括
风湿性关节炎患者患有脏问题往往需要调整药物剂量. 这一审查强调了需要明确的指导方针对抗风湿性药物剂量在功能衰竭的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
背景情况:
- 类风湿性关节炎 (RA) 的功能衰竭源于药物毒性,并发症和炎症.
- 尽管治疗方法得到改善,但约25%的RA患者仍面临脏并发症.
- 关于抗风湿药物安全性和功能减弱患者的剂量存在有限的数据.
研究的目的:
- 审查当前关于抗风湿药物剂量在功能不全的知识.
- 为强调需要精确,透明和一致的剂量建议,RA患者慢性病.
主要方法:
- 关于在功能障碍中使用抗风湿药物的现有研究的文献综述.
- 在类风湿性关节炎患者中分析导致功能衰竭的因素.
主要成果:
- 当代的RA治疗已经减少了功能衰竭的发生率,但它仍然是一个重大问题.
- 许多抗风湿药物缺乏彻底的安全性和剂量研究,在患者减少膜过.
结论:
- 剂量修改对于患有功能不全的RA患者至关重要.
- 进一步的研究是必不可少的,以建立基于证据的抗风湿性药物的剂量指南在慢性病,以改善患者的护理.
相关概念视频
Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630


